v3.26.1
Condensed Financial Information of the Parent Company - Schedule of Condensed Statements of Financial Position (Details) - Parent Company [Member]
¥ in Thousands
12 Months Ended
Dec. 31, 2025
CNY (¥)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
CNY (¥)
Dec. 31, 2023
CNY (¥)
Dec. 31, 2025
USD ($)
Current assets          
Cash and bank equivalents ¥ 82   ¥ 84   $ 12
Prepayments, other receivables and other assets 52,616   228,170   7,524
Total current assets 52,698   228,254   7,536
Investments in subsidiaries 681,562   341,332   97,463
Total non-current assets 681,562   341,332   97,463
Total assets 734,260   569,586   104,999
Commitments and Contingencies      
SHAREHOLDERS’ EQUITY          
Treasury shares (31)   (31)   (4)
Additional paid-in capital 1,303,581   1,181,993   186,410
Statutory surplus reserve 10,531   9,367   1,506
Accumulated losses (579,876)   (621,794)   (82,921)
Total equity 734,260   569,586   104,999
Administrative expenses (1,480) $ (212) (9,348) ¥ (9,628)  
Financial expense, net (3,564) (510) (13) (508)  
Share of income/(loss) of subsidiaries 47,754 6,828 (43,015) 109,401  
PROFIT/(LOSS) BEFORE TAX 42,710 6,106 (52,376) 99,265  
Income tax expenses (2)  
Net profit/(loss) for the year 42,710 6,106 (52,376) 99,263  
Net profit attribute to ordinary shareholders 42,710 6,106 (52,376) 99,263  
Net profit attribute to non-controlling interests (372) (53) 12 2,217  
Comprehensive income/(loss) 43,082 6,159 (52,388) 97,046  
Net cash (used in) generated from operating activities (37,400) (5,348) 8,911 (8,775)  
Net cash flows used in investing activities (98,512) (14,087)  
Net cash used in financing activities 136,045 19,454 (9,348) (9,498)  
Exchange rate effect on cash and cash equivalents (51) (7) (2) (501)  
Net (decrease) increase in cash and cash equivalents 82 12 (439) (18,774)  
Cash and cash equivalents at beginning of the year 523 19,297  
Cash and cash equivalents at end of the year 82 $ 12 84 ¥ 523  
Class B Ordinary Shares          
SHAREHOLDERS’ EQUITY          
Ordinary shares (US$0.0001 par value; 500,000,000 shares authorized as at December 31, 2024 and December 31, 2025; 70,000,000 shares and 76,048,501 shares issued and outstanding as at December 31, 2024 and December 31, 2025, respectively) ¥ 55   ¥ 51   $ 8